VIENNA — Twenty-four weeks of treatment with Harvoni yielded a 12-week sustained virologic response...
Read More
UT Health Science Center San Antonio doctor presents results of daclatasvir regimen SAN ANTONIO...
Merck & Co. said Friday that its experimental drug combination for treating chronic hepatitis...
A number of new, highly effective oral treatments for various types of hepatitis C...
3rd Annual Texas Nursing and NP/PA Liver Disease Conference
This edition contains the following: Interferon-free, All Oral DAA Regimens for Genotype 1 Ultra-short Treatments...
Boston—Can treatment of hepatitis C infection with new direct-acting antivirals (DAAs) be shortened to...
Following this program, participants should be better able to: Use in a clinical setting important...